<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Staph Infections</title><link href="http://www.fightingobesitynetwork.com/topic/Staph%20Infections" rel="alternate"></link><id>http://www.fightingobesitynetwork.com/topic/Staph Infections</id><updated>2010-03-15T15:45:22Z</updated><entry><title>Antiseptic baths help fight 'superbug' infections</title><link href="http://www.fightingobesitynetwork.com/article/Antiseptic%20baths%20help%20fight%20%27superbug%27%20infections" rel="alternate"></link><updated>2010-03-15T15:45:22Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fightingobesitynetwork.com,2010-03-15:/article/Antiseptic%20baths%20help%20fight%20%27superbug%27%20infections</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - Bathing severely injured intensive-care patients with antiseptic-soaked washcloths can cut their risk of developing certain types of infections, and also seems to help keep drug-resistant bacteria at bay, new research shows.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Trauma patients are particularly vulnerable to hospital-acquired infections, Dr. Heather L. Evans of &lt;a title="Harborview Medical Center" href=...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Microbiology"></category><category term="Bacteria"></category><category term="Reuters Group plc"></category><category term="Medical Errors and Malpractice"></category><category term="Healthcare Associated Infections"></category><category term="Shirin Towfigh"></category></entry><entry><title>U.S. hospital infections killed 48,000: report</title><link href="http://www.fightingobesitynetwork.com/article/U.S.%20hospital%20infections%20killed%2048%2C000%3A%20report" rel="alternate"></link><updated>2010-02-22T13:15:30Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-22:/article/U.S.%20hospital%20infections%20killed%2048%2C000%3A%20report</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Pneumonia and blood-borne infections caught in hospital killed 48,000 patients and cost $8.1 billion in 2006, according to a report released on Monday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The study is one of the first to put a price tag on the widespread problem, which is worsening and which some experts say is adding to the growing cost of healthcare in the &lt;a title="United States" href="/topic/United+Sta...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Respiratory Medicine"></category><category term="Medical Treatments and Procedures"></category><category term="Surgery"></category><category term="Pneumonia"></category><category term="Reuters Group plc"></category><category term="Maggie Fox"></category><category term="Resources for the Future"></category><category term="Medical Errors and Malpractice"></category><category term="Healthcare Associated Infections"></category></entry><entry><title>J&amp;J partner says EU rejecting skin infection drug</title><link href="http://www.fightingobesitynetwork.com/article/J%26J%20partner%20says%20EU%20rejecting%20skin%20infection%20drug" rel="alternate"></link><updated>2010-02-22T08:16:38Z</updated><author><name>AP Features</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-22:/article/J%26J%20partner%20says%20EU%20rejecting%20skin%20infection%20drug</id><summary type="html">&amp;amp;amp;lt;div&amp;amp;amp;gt;&amp;amp;amp;lt;p&amp;amp;amp;gt;Johnson &amp;amp;amp;amp;amp; Johnson said Friday it terminated a partnership to develop a highly touted drug for MRSA and other dangerous skin infections, after European regulators rejected it over concerns that data from tests run by J&amp;amp;amp;amp;amp;J isn't reliable.&amp;amp;amp;lt;/p&amp;amp;amp;gt;&amp;amp;amp;lt;p&amp;amp;amp;gt;&lt;a title="Switzerland" href="/topic/Switzerland" &gt;Switzerland&lt;/a&gt;'s &lt;a title="Basilea Pharmaceutica Ltd." href="/topic/Basilea+Pha...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Western Europe"></category><category term="New Brunswick"></category><category term="Basel"></category><category term="Edward Jones"></category><category term="Steve Brozak"></category><category term="WBB Securities LLC"></category><category term="Miller Tabak + Co. LLC"></category><category term="Linda Bannister"></category><category term="Infectious Diseases Society of America"></category><category term="Basilea Pharmaceutica Ltd."></category><category term="EMEA Committee for Medicinal Products for Human Use"></category><category term="Harbor-UCLA Medical Center"></category><category term="Janssen-Cilag GmbH"></category><category term="Vibativ"></category><category term="Brad Spellberg"></category></entry><entry><title>Research-sleuths succeed in tracking MRSA super-bacteria</title><link href="http://www.fightingobesitynetwork.com/article/Research-sleuths%20succeed%20in%20tracking%20MRSA%20super-bacteria" rel="alternate"></link><updated>2010-02-22T16:48:58Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-22:/article/Research-sleuths%20succeed%20in%20tracking%20MRSA%20super-bacteria</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Scientists have succeeded in tracking the patient-to-patient transmission of the multi-drug resistant MRSA bacteria, which they hope will allow for better control and prevention of the dreaded superbug.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;For the first time, researchers have determined how MRSA spreads from one person to another, particularly in hospitals -- the setting where the bacteria often proliferates.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;"The ability to trac...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Western Europe"></category><category term="Southeast Asia"></category><category term="Oceania"></category><category term="The Sanger Institute"></category><category term="University of Bath"></category><category term="Centers for Disease Control and Preventions"></category><category term="Ed Feil"></category><category term="Department of Biology and Biochemistry"></category></entry><entry><title>Gene sleuthing tracks variation in MRSA superbug</title><link href="http://www.fightingobesitynetwork.com/article/Gene%20sleuthing%20tracks%20variation%20in%20MRSA%20superbug" rel="alternate"></link><updated>2010-02-22T16:56:26Z</updated><author><name>AP Features</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-22:/article/Gene%20sleuthing%20tracks%20variation%20in%20MRSA%20superbug</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;A new kind of genetic sleuthing suggests hospital outbreaks of drug-resistant staph bacteria don't always spread from one patient to another, but that numerous people — patients, visitors or staff — bring in the deadly germ.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The finding came as British scientists used in-depth gene scanning to track how a dangerous strain of this bacteria, called MRSA, has spread around the world.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The result, ...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Western Europe"></category><category term="Southeast Asia"></category><category term="The Sanger Institute"></category><category term="Buddy Creech"></category><category term="Sharon Peacock"></category></entry><entry><title>High-resolution gene technique zooms in on superbug</title><link href="http://www.fightingobesitynetwork.com/article/High-resolution%20gene%20technique%20zooms%20in%20on%20superbug" rel="alternate"></link><updated>2010-02-22T16:57:02Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-22:/article/High-resolution%20gene%20technique%20zooms%20in%20on%20superbug</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Scientists have found a way to track minutely-differing strains of the "superbug" MRSA as they spread between people and across the globe, a finding that could aid efforts to control the deadly bacteria.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;An international team lead by researchers from &lt;a title="United Kingdom" href="/topic/United+Kingdom" &gt;Britain&lt;/a&gt;'s &lt;a title="The Sanger Ins...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Western Europe"></category><category term="Southeast Asia"></category><category term="Reuters Group plc"></category><category term="Oceania"></category><category term="The Sanger Institute"></category><category term="Britain's Cambridge University"></category><category term="Simon Harris"></category><category term="European Centre for Disease Prevention and Control"></category></entry><entry><title>Polar bear poo helps in superbug hunt</title><link href="http://www.fightingobesitynetwork.com/article/Polar%20bear%20poo%20helps%20in%20superbug%20hunt" rel="alternate"></link><updated>2010-02-22T20:46:36Z</updated><author><name>Reuters US Online Report Science News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-22:/article/Polar%20bear%20poo%20helps%20in%20superbug%20hunt</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Polar bear droppings are helping scientists shed light on the spread of deadly antibiotic-resistant superbugs.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Bacteria such as methicillin-resistant staphylococcus aureus (MRSA) are a growing problem in hospitals and researchers are anxious to understand how they evolve.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Norwegian researchers said they had fo...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Microbiology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="Svalbard"></category><category term="Ben Hirschler"></category><category term="University of Tromso"></category></entry><entry><title>Screening could curb hospital superbug</title><link href="http://www.fightingobesitynetwork.com/article/Screening%20could%20curb%20hospital%20superbug" rel="alternate"></link><updated>2010-02-22T21:56:53Z</updated><author><name>Reuters US Online Report Science News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-22:/article/Screening%20could%20curb%20hospital%20superbug</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Patients who undergo treatment at more than one hospital in &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt; should be screened for the drug-resistant "superbug" MRSA to help prevent its spread, scientists said on Tuesday.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Dutch researchers who studied methicillin-resistant staphylococcus aureus (MRSA), which causes difficult-to-treat infect...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Public Library of Science Medicine"></category><category term="The University Medical Center Groningen"></category><category term="European Centre for Disease Prevention and Control"></category><category term="Hajo Grundmann"></category></entry><entry><title>Better antiseptic curbs post-surgery infections</title><link href="http://www.fightingobesitynetwork.com/article/Better%20antiseptic%20curbs%20post-surgery%20infections" rel="alternate"></link><updated>2010-02-23T00:27:18Z</updated><author><name>AP News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-23:/article/Better%20antiseptic%20curbs%20post-surgery%20infections</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;Studies: Switching antiseptic prep, screening patients for bacteria cut post-op infections&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Looks like doctors aren't the only ones who should scrub before surgery. Bathing patients with an antiseptic and squirting medicated ointment up their noses dramatically cut the rate of dangerous staph infections afterward, researchers found.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;A second study found the antiseptic did a be...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Medical Treatments and Procedures"></category><category term="Surgery"></category><category term="Western Europe"></category><category term="New England States"></category><category term="Richmond (Virginia)"></category><category term="Cook County"></category><category term="Robert Weinstein"></category><category term="Erasmus Medical Center"></category><category term="Michael DeBakey"></category><category term="John H. Stroger Jr. Hospital of Cook County"></category><category term="Richard Wenzel"></category><category term="Medical Errors and Malpractice"></category><category term="Mupirocin"></category><category term="Cardinal Health Inc."></category><category term="CareFusion Corporation"></category><category term="Healthcare Associated Infections"></category><category term="Rabih Darouiche"></category><category term="Henri Verbrugh"></category></entry><entry><title>Solution to killer superbug found in Norway</title><link href="http://www.fightingobesitynetwork.com/article/Solution%20to%20killer%20superbug%20found%20in%20Norway" rel="alternate"></link><updated>2010-02-23T07:45:29Z</updated><author><name>AP News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-23:/article/Solution%20to%20killer%20superbug%20found%20in%20Norway</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;&lt;a title="Norway" href="/topic/Norway" &gt;Norway&lt;/a&gt; finds way to control infection that kills thousands elsewhere: Cut antibiotics&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Aker University Hospital is a dingy place to heal. The floors are streaked and scratched. A light layer of dust coats the blood pressure monitors. A faint stench of urine and bleach wafts from a pile of soiled bedsheets dropped in a corner.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Look cl...</summary><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Social Policy"></category><category term="Public Health Policy"></category><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Middle East"></category><category term="Western Europe"></category><category term="The Balkans"></category><category term="Southeast Asia"></category><category term="Tokyo"></category><category term="The Associated Press"></category><category term="East Asia"></category><category term="Nordic Countries"></category><category term="Batavia"></category><category term="Oslo"></category><category term="7-Eleven Inc."></category><category term="Billings (Montana)"></category><category term="Martha Mendoza"></category><category term="Nieman Foundation for Journalism"></category><category term="Margie Mason"></category><category term="Medical Errors and Malpractice"></category><category term="London (England)"></category><category term="Healthcare Associated Infections"></category><category term="Lynne Liebowitz"></category><category term="Robert Muder"></category><category term="Barry Farr"></category><category term="Jan Hendrik-Binder"></category><category term="John Birger Haug"></category><category term="John Jernigan"></category><category term="Satoshi Hori"></category><category term="Juntendo University Hospital"></category><category term="Queen Elizabeth Hospital"></category></entry><entry><title>One superbug infection costs hospital $60,000: study</title><link href="http://www.fightingobesitynetwork.com/article/One%20superbug%20infection%20costs%20hospital%20%2460%2C000%3A%20study" rel="alternate"></link><updated>2010-02-23T15:36:46Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-23:/article/One%20superbug%20infection%20costs%20hospital%20%2460%2C000%3A%20study</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A single patient infected with the increasingly common "superbug" known as MRSA can cost a hospital $60,000, &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; researchers reported Tuesday.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Their study of seven hospitals and health facilities shows that taking action, even expensive action, to fight infections can save money, t...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Reuters Group plc"></category><category term="Maggie Fox"></category><category term="Public Library of Science"></category><category term="Medical Errors and Malpractice"></category><category term="Healthcare Associated Infections"></category><category term="Deverick Anderson"></category></entry><entry><title>Drug-resistant staph infections rising in US: study</title><link href="http://www.fightingobesitynetwork.com/article/Drug-resistant%20staph%20infections%20rising%20in%20US%3A%20study" rel="alternate"></link><updated>2010-02-24T01:00:00Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-24:/article/Drug-resistant%20staph%20infections%20rising%20in%20US%3A%20study</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Cases of antibiotic-resistant staph infections usually acquired in the community are growing in the &lt;a title="United States" href="/topic/United+States" &gt;United States&lt;/a&gt; and rapidly spreading to hospitals, researchers said Tuesday.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Methicillin-resistant Staphylococcus aureus (MRSA), which can penetrate wounds and cause lethal bloodstream and lung infections, kills about 20,000 each year in the United States, according to the...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Resources for the Future"></category><category term="Medical Errors and Malpractice"></category><category term="Eili Klein"></category><category term="Healthcare Associated Infections"></category></entry><entry><title>Drug-resistant bacteria on increase in U.S.: study</title><link href="http://www.fightingobesitynetwork.com/article/Drug-resistant%20bacteria%20on%20increase%20in%20U.S.%3A%20study" rel="alternate"></link><updated>2010-02-24T01:27:07Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-24:/article/Drug-resistant%20bacteria%20on%20increase%20in%20U.S.%3A%20study</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Cases of a drug-resistant bacterial infection known as MRSA have risen by 90 percent since 1999, and they are increasingly being acquired outside hospitals, researchers reported on Tuesday.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;They found two new strains of methicillin-resistant Staphylococcus aureus -- MRSA for short -- were circulating in patients and they are different from...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Reuters Group plc"></category><category term="Medical Errors and Malpractice"></category><category term="Healthcare Associated Infections"></category></entry><entry><title>Antibiotic overuse threatens modern medicine: experts</title><link href="http://www.fightingobesitynetwork.com/article/Antibiotic%20overuse%20threatens%20modern%20medicine%3A%20experts" rel="alternate"></link><updated>2010-02-24T07:29:03Z</updated><author><name>Reuters US Online Report Top News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-24:/article/Antibiotic%20overuse%20threatens%20modern%20medicine%3A%20experts</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Overuse of antibiotics in &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt; is building widespread resistance and threatening to halt vital medical treatments such as hip replacements, intensive care for premature babies and cancer therapies, health experts say.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Dominique Monnet of the &lt;a title="European Centre for Disease Prevention and Cont...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Biology"></category><category term="Microbiology"></category><category term="Bacteria"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Premature Births"></category><category term="European Centre for Disease Prevention and Control"></category><category term="Children's Health"></category></entry><entry><title>Novartis buys rights to next-generation antibiotic</title><link href="http://www.fightingobesitynetwork.com/article/Novartis%20buys%20rights%20to%20next-generation%20antibiotic" rel="alternate"></link><updated>2010-02-24T21:10:55Z</updated><author><name>AP News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-24:/article/Novartis%20buys%20rights%20to%20next-generation%20antibiotic</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;&lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis&lt;/a&gt; to pay up to $485M for rights to &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; firm's antibiotic for drug-resistant bacteria&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Novartis AG said Thursday it has bought worldwide rights to a new antibiotic drug developed by U.S. company &lt;a title="Paratek Pharmaceuticals Inc." href="/topic/Paratek+Pharmaceuticals+Inc." &gt;Paratek Pharmaceu...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Microbiology"></category><category term="Bacteria"></category><category term="Paratek Pharmaceuticals Inc."></category><category term="Beverly Armstrong"></category></entry><entry><title>Beaches pose super-bug risk: study</title><link href="http://www.fightingobesitynetwork.com/article/Beaches%20pose%20super-bug%20risk%3A%20study" rel="alternate"></link><updated>2010-02-25T08:18:22Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-25:/article/Beaches%20pose%20super-bug%20risk%3A%20study</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The so-called superbug MRSA, a multiresistant strain of staphylococcus usually found in hospitals, has been discovered for the first time on &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; beaches, a study said.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The antibiotic-resistant strain, which is increasingly found in prisons, gym locker rooms and homes, can cause skin conditions and organ ailments and serious and sometimes fatal cases of pneumonia.&amp;amp;lt;...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Western Europe"></category><category term="East Asia"></category><category term="Marilyn Roberts"></category><category term="Interscience Conference on Antimicrobial Agency and Chemotherapy"></category><category term="Jim Sliwa"></category></entry><entry><title>Dangerous staph germs found at West Coast beaches</title><link href="http://www.fightingobesitynetwork.com/article/Dangerous%20staph%20germs%20found%20at%20West%20Coast%20beaches" rel="alternate"></link><updated>2010-02-25T08:24:59Z</updated><author><name>AP News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-25:/article/Dangerous%20staph%20germs%20found%20at%20West%20Coast%20beaches</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;A day at the beach? Shower afterward. Sand, water can hold dangerous staph germs, study finds&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Dangerous staph bacteria have been found in sand and water for the first time at five public beaches along the coast of &lt;a title="Washington" href="/topic/Washington" &gt;Washington&lt;/a&gt;, and scientists think the state is not the only one with this problem.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The germ is MRSA, or methicill...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Microbiology"></category><category term="Puget Sound"></category><category term="South Florida"></category><category term="University Health System Inc."></category><category term="Marilyn Roberts"></category><category term="Lance Peterson"></category></entry><entry><title>Study exposes how bacteria resist antibiotics</title><link href="http://www.fightingobesitynetwork.com/article/Study%20exposes%20how%20bacteria%20resist%20antibiotics" rel="alternate"></link><updated>2010-02-25T09:10:59Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-25:/article/Study%20exposes%20how%20bacteria%20resist%20antibiotics</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;&lt;a title="Chicago" href="/topic/Chicago" &gt;CHICAGO&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Scientists have discovered how bacteria fend off a wide range of antibiotics, and blocking that defense mechanism could give existing antibiotics more power to fight dangerous infections.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Researchers at &lt;a title="New York University" href="/topic/New+York+University" &gt;New York University&lt;/a&gt; said ...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Microbiology"></category><category term="Bacteria"></category><category term="Reuters Group plc"></category><category term="Maggie Fox"></category><category term="NYU Langone Medical Center"></category><category term="Evgeny Nudler"></category></entry><entry><title>Report helps quell fear of "superbug" epidemic</title><link href="http://www.fightingobesitynetwork.com/article/Report%20helps%20quell%20fear%20of%20%22superbug%22%20epidemic" rel="alternate"></link><updated>2010-02-25T10:44:10Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-25:/article/Report%20helps%20quell%20fear%20of%20%22superbug%22%20epidemic</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - In doctors' offices in the &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt;, skin infections have not become more common since the "superbug" MRSA began showing up in communities.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;This finding contrasts with studies indicating that visits to U.S. emergency rooms and all non-hospital-inpatient medical settings for skin in...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Emergency Medicine"></category><category term="Reuters Group plc"></category><category term="Skin Health"></category><category term="Daniel Pallin"></category><category term="National Ambulatory Medical"></category></entry><entry><title>Forest Laboratories, AstraZeneca sign partnership</title><link href="http://www.fightingobesitynetwork.com/article/Forest%20Laboratories%2C%20AstraZeneca%20sign%20partnership" rel="alternate"></link><updated>2010-02-25T21:20:48Z</updated><author><name>AP News</name></author><id>tag:www.fightingobesitynetwork.com,2010-02-25:/article/Forest%20Laboratories%2C%20AstraZeneca%20sign%20partnership</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;&lt;a title="Forest Laboratories Inc." href="/topic/Forest+Laboratories+Inc." &gt;Forest Laboratories&lt;/a&gt;, &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt; sign deal to develop, sell treatment for infections&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Forest Laboratories Inc. and AstraZeneca said Wednesday they are collaborating to develop and sell a next-generation treatment for antibiotic-resistant, or Staph, infections and hos...</summary><category term="Contagious and Infectious Diseases"></category><category term="Staph Infections"></category><category term="Health Care Issues"></category><category term="Antimicrobial Resistance"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="London"></category><category term="East Asia"></category></entry></feed>